Medical anticancer treatment of lung cancer associated with comorbidities: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medical anticancer treatment of lung cancer associated with comorbidities: A review

Published:2015-03 Issue:3 Volume:87 Page:241-248
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Sculier J.P.,Botta I.,Bucalau A.M.,Compagnie M.,Eskenazi A.,Fischler R.,Gorham J.,Mans L.,Rozen L.,Speybrouck S.,Wang X.,Meert A.P.,Berghmans Th.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference83 articles.

1. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study;Janssen-Heijnen;Lung Cancer,1998

2. Role of comorbidity on survival after radio- and chemotherapy for non-surgically treated lung cancer;Mellemgaard;J Thorac Oncol,2014

3. Comorbid illnesses and health care utilization among Medicare beneficiaries with lung cancer;Dy;Crit Rev Oncol Hematol,2006

4. Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients;Fiegl;Lung Cancer,2014

5. Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review;Lee;J Clin Oncol,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Drug-Drug Interactions in Outpatient Lung Cancer Patients in a University Hospital;Pharmacology;2024

2. Insuffisance d’organe (cœur, rein, foie) et traitements du cancer pulmonaire;Revue des Maladies Respiratoires Actualités;2023-10

3. Emphysema: the risk of cancer and the impact on cancer care;Lung Diseases and Cancer;2022-11

4. Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study;Acta Oncologica;2022-01-11

5. Co-morbidités et prise en charge des cancers bronchiques;Revue des Maladies Respiratoires Actualités;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3